Natco Pharma launches a prevalent equal to Revlimid inside the Canadian marketplace

Natco Pharma launches a prevalent equal to Revlimid inside the Canadian marketplace

by admin- Thursday, September 2nd, 2021 03:41:51 PM

Natco Pharma (Canada) Inc., a subsidiary of Natco Pharma the launch of PrNAT-LENALIDOMIDE Capsules, the primary conventional alternative to Revlimid to be authorised by way of Health Canada.

News Updates